An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2016-09-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics,
pharmacodynamics and preliminary clinical efficacy of VTP-38543 administered as a cream,
twice-daily, for 28 days in otherwise healthy adult male and female participants with mild to
moderate atopic dermatitis.